IL36G and asthma: Similar results were observed in airway epithelial cells, where luteolin (20 μmol/L) suppressed IL-36γ-induced MAPK activation and downstream IL-1β release, indicating its role in mitigating neutrophil-driven asthma by blocking the IL-36γ/MAPK axis (Qiao et al., 2023).